pharm Q3 - meds affecting the CNS and NS

0.0(0)
studied byStudied by 0 people
GameKnowt Play
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/45

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

46 Terms

1
New cards

class: neuromuscular blocking agents

depolarizing and nondepolarizing

2
New cards

depolarizing meds

succinylcholine

3
New cards

succinylcholine function (depolarizing neuromuscular blocking agent)

causes sustained depolarization of the muscle resulting in muscle paralysis, blocks the repolarization of muscles

4
New cards

succinylcholine onset and duration (depolarizing neuromuscular blocking agent)

onset 45 to 60sec, duration 4 to 6min

5
New cards

succinylcholine therapeutic use (depolarizing neuromuscular blocking agent)

adjuncts to general anesthesia, endotracheal intubation and endoscopy, control spontaneous resp mvmts, seizure control

6
New cards

succinylcholine complications (depolarizing neuromuscular blocking agent)

resp arrest, prolonged apnea, malignant hyperthermia, hyperkalemia - no reversal for depolarizing agents

7
New cards

succinylcholine contraindications (depolarizing neuromuscular blocking agent)

hyperkalemia, severe trauma, burns

8
New cards

non depolarizing neuromuscular agents

rocuronium, vecuronium, pancuronium

9
New cards

rocuronium, vecuronium, pancuronium - non depolarizing neuromuscular agents

blocks Ach at the neuromuscular junction resulting in muscle relaxation and hypotension

10
New cards

rocuronium, vecuronium, pancuronium reversal agent (non depolarizing neuromuscular agents)

neostigmine

11
New cards

rocuronium, vecuronium, pancuronium therapeutic use (non depolarizing neuromuscular agents)

same as depolarizing

12
New cards

rocuronium, vecuronium, pancuronium complications (non depolarizing neuromuscular agents)

resp arrest, prolonged apnea

13
New cards

class: muscle relaxants and antispasmodics - centrally acting

diazepam (valium), baclofen, cyclobenzaprine (flexeril)

14
New cards

diazepam (valium) pharm action (muscle relaxants and antispasmodics - centrally acting)

mimics GABA at receptor in spinal cord and brain

15
New cards

GABA

primary inhibitory neurotransmitter in the brain and spinal cord

16
New cards

class: muscle relaxants and antispasmodics - peripherally acting

dantrolene (ryanodex, dantrium)

17
New cards

dantrolene pharm action (muscle relaxants and antispasmodics - peripherally acting)

inhibit muscle contraction by preventing release of calcium in skeletal muscle

18
New cards

dantrolene therapeutic use (muscle relaxants and antispasmodics - peripherally acting)

spasticity relief, malignant hyperthermia by blocking release of calcium from sarcoplasmic reticulum of skeletal muscle cells

19
New cards

class: muscarinic agonists

bethanechol

20
New cards

bethanechol pharm action (muscarinic agonists)

relax trigone and sphincter muscles, contract detrusor muscle

21
New cards

bethanechol therapeutic use (muscarinic agonists)

underactive bladder, nonobstructive urinary retention

22
New cards

class: muscarinic antagonists

oxybutynin

23
New cards

oxybutynin pharm action (muscarinic antagonists)

prevent contractions of bladder

24
New cards

oxybutynin therapeutic use (muscarinic antagonists)

overactive bladder

25
New cards

oxybutynin complications (muscarinic antagonists)

constipation, dry mouth, blurred vision, photophobia, dry eye, tachycardia, anhydrosis

26
New cards

class: benzodiazepines

diazepam (valium), alprazolam (xanax), lorazepam (ativan), midazolam (versed)

27
New cards

diazepam pharm action (benzodiazepines)

enhance GABA in the CNS to reduce neuronal excitability

28
New cards

diazepam complications (benzodiazepines)

CNS depression, paradoxical response

29
New cards

paradoxical response manifestations

insomnia, excitation, euphoria, anxiety, rage

30
New cards

benzodiazepine antidote

flumazenil (romazicon)

31
New cards

class: non benzodiazepines

zolpidem (ambien)

32
New cards

zolpidem (ambien) pharm action (nonbenzodiazepines)

enhances GABA in the CNS by preferential binding to the 1a receptor subunits

33
New cards

zolpidem (ambien) therapeutic use (nonbenzodiazepines)

insomnia short term

34
New cards

class: melatonin agonist

ramelteon (rozerem)

35
New cards

ramelteon pharm action (melatonin agonist)

activate melatonin receptors, highly selective receptor type 1 and 2 agonist

36
New cards

ramelteon therapeutic use (melatonin agonist)

insomnia chronic

37
New cards

ramelteon interactions (melatonin agonist)

avoid high fat meals b4 taking, take 30min b4 bedtime

38
New cards

IV non opioid benzo anesthetics

midazolam (versed), diazepam (valium), lorazepam (ativan)

39
New cards

IV non opioid barbiturate anesthetics

pentobarbital sodium (nembutal)

40
New cards

IV non opioid anesthetics therapeutic use

moderate conscious sedation, maintain anesthesia, mechanical ventilation

41
New cards

IV non opioid anesthetics complications - propofol

infection

42
New cards

IV non opioid anesthetics complications - ketamine

psychological reactions, <15yrs and >65yrs at higher risk, avoid use in pts with history of mental illness

43
New cards

IV non opioid anesthetics admin - propofol

inject into large vein to decrease pain

44
New cards

IV opioids

fetanyl, morphine

45
New cards

fetanyl, morphine complications (IV opioids)

resp and cardiovascular depression with high hypotension risk

46
New cards

what are fetanyl and morphine overdose treated with (IV opioids)

naloxone (narcan)